ClinicalTrials.gg
CompletedNCT02767427Updated Feb 6, 2023Results posted

The Value of Home Chlorhexidine Pre-Surgical Wash Before Spine Surgery

An interventional study of Chlorhexidine Wipes and No intervention in Infection and Spinal Injuries, sponsored by Columbia University. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-02-06.

Sponsored by Columbia University · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The study team hypothesizes that at-home cleansing of the surgical site with chlorhexidine wipes provide no added benefit to decreasing microbial activity or preventing surgical site infections.

Patients will be randomized to the chlorhexidine or no additional intervention groups. Patients will be randomized to use 4% chlorhexidine cloths, while the other half receive no additional intervention. Those randomized into the chlorhexidine gluconate (CHG) home-application group will be asked to shower the night before surgery, and to use a standardized pre-packaged CHG wipe (that the patients would receive at their pre-surgical consultation) on their surgical site after thoroughly drying those areas. The patients will be asked to use a second wipe in each area the morning of surgery. The surgical sites will be analyzed in two groups: anterior cervical and posterior spine. Each of these two groups will be randomized separately. All patients will undergo a standardized preoperative cleansing regimen. Once positioned, they will be cleansed with an alcohol solution. Then, the surgical site (either the anterior portion of the neck or the posterior area of the spine) will be scrubbed with chlorhexidine soaked brushes and then painted with chlorhexidine solution. Perioperative antibiotics will be given per attending surgeon preference. Cutaneous samples will be taken from the surgical site of each patient at each time point.

Read the detailed description

To the investigator's knowledge no prior study has evaluated the effects of cleaning the skin at home before surgery in patients undergoing spine surgery. This study will investigate whether patients who use a chlorhexidine cleansing wipe have decreased amounts of bacteria on their skin when they arrive for scheduled spine surgery. Spine surgeons strive to decrease infections in their patients, so it is important to see if this intervention helps to do this.

02

Conditions studied

  • Infection
  • Spinal Injuries

Keywords

  • Infection Control
  • Preoperative Care
  • Chlorhexidine
  • Pre-Surgical Wash
  • Spine Surgery
  • Surgical site infections
  • Cutaneous bacterial load on skin
03

In context

Infections

2,093 studies on the registry are indexed under Infections; 364 are open to participants now.

This study's enrollment of 40 is below the median of 113 across 1,304 interventional studies indexed under Infections.

Browse Infections studies →

Lead sponsor

Columbia University is the lead sponsor of 1,136 studies on the registry; 195 are open to participants now.

Of its 180 completed or terminated interventional studies of FDA-regulated products, 148 (82%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 18 years old or older
  • Scheduled for elective spine surgery at Columbia University Medical Center

Exclusion criteria

Exclusion Criteria:

  • Unable to apply at-home chlorhexidine wipe by themselves
  • Deemed "high risk" preoperatively by the treating surgeon
  • Diagnosed with spine trauma
  • Undergoing deformity correction surgery
  • Unable to consent to the terms of the surgery
  • Known infection at time of the index procedure
  • Hospitalized within 1 week pre-operatively
  • Allergic to chlorhexidine
  • End stage renal disease on dialysis
  • Local or systemic skin disease (such as psoriasis, eczema, etc.)
  • Open skin wounds
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Immunosuppression

A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.

Read whether the line is about a condition or about medicines, and which medicines and doses it means.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Care provider, Investigator)
Enrollment
40 participants (actual)

Study arms

  • Active comparator
    At-Home Chlorhexidine

    Those randomized into the chlorhexidine group will be asked to shower the night before surgery, and to use a standardized pre-packaged Chlorhexidine Wipes (chlorhexidine gluconate wipes) on their surgical site after thoroughly drying those areas. They will be asked to use a second wipe in each area the morning of surgery. Those who forget to use the wipe in the morning were allowed to use the wipe in the pre-operative area and included if this occurs more than one hour before skin prep.

    Device: Chlorhexidine Wipes

  • Experimental
    No At-Home Chlorhexidine

    Participants in this group will not use chlorhexidine wipes (no intervention), as is standard of care, prior to their surgical site being cleansed by the surgical team pre-operatively.

    Other: No intervention

Interventions

  • DeviceChlorhexidine Wipes

    (Standard of Care) Chlorhexidine wipes are a commonly used pre-operative skin cleansing measure, designed to reduce bacterial load on the skin of the surgical site.

    Also known as: 4% Chlorhexidine Wipes, Chlorhexidine Gluconate, Skin Prep Cloths, Sage Skin Prep Cloths

  • OtherNo intervention

    Chlorhexidine wipes will not be used though it is a commonly used pre-operative skin cleansing measure.

06

What researchers measure

Primary outcomes

  1. Number of Patients With Cutaneous Bacterial Load After Surgery

    All specimens were taken by a sterile BD E-Swab. All samples will be sent immediately after acquisition to the microbiology lab for analysis within four hours.

    Time frame: Pre-Surgery and Post Surgery, up to 4 hours

07

Results

Posted Jul 16, 2019

Participant flow

Participant flow — Overall Study
MilestoneAt-Home ChlorhexidineNo At-Home Chlorhexidine
Started2119
Completed2119
Not completed00

Outcome measures

PrimaryNumber of Patients With Cutaneous Bacterial Load After Surgery

All specimens were taken by a sterile BD E-Swab. All samples will be sent immediately after acquisition to the microbiology lab for analysis within four hours.

Time frame:
Pre-Surgery and Post Surgery, up to 4 hours
Reported as:
Count of participants · Participants
Number of Patients With Cutaneous Bacterial Load After Surgery
ParticipantsAt-Home ChlorhexidineNo At-Home Chlorhexidine
Presurgery Bacterial Colony Count — Subjects with bacterial colonies018
Presurgery Bacterial Colony Count — Subjects without bacterial colonies211
Postsurgical Bacterial Colony Count — Subjects with bacterial colonies00
Postsurgical Bacterial Colony Count — Subjects without bacterial colonies2119
Statistical analysis
  • At-Home Chlorhexidine vs No At-Home Chlorhexidine · t-test, 1 sided · p = <0.05Two one-sided t-tests were conducted with 18 in each group.

Adverse events

Collected over The forty enrolled patients were all consented and followed for data collection over the span of 15 months. Each patient was followed for up to 6 weeks after surgery to ensure that there were no postoperative infections.. Non-serious events are listed at a 5% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
At-Home Chlorhexidine0/21 (0%)0/21 (0%)0/21 (0%)
No At-Home Chlorhexidine0/19 (0%)0/19 (0%)0/19 (0%)

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)At-Home ChlorhexidineNo At-Home ChlorhexidineTotal
<=18 years000
Between 18 and 65 years181230
>=65 years3710
Age, Continuous
Age, Continuous(years)At-Home ChlorhexidineNo At-Home ChlorhexidineTotal
Mean56.05 ± 9.1259.79 ± 13.1057.87 ± 11.39
Sex: Female, Male
Sex: Female, Male(Participants)At-Home ChlorhexidineNo At-Home ChlorhexidineTotal
Female7613
Male141327
Race (NIH/OMB)
Race (NIH/OMB)(Participants)At-Home ChlorhexidineNo At-Home ChlorhexidineTotal
American Indian or Alaska Native000
Asian022
Native Hawaiian or Other Pacific Islander000
Black or African American123
White191433
More than one race000
Unknown or Not Reported112
Region of Enrollment
Region of Enrollment(Participants)At-Home ChlorhexidineNo At-Home ChlorhexidineTotal
United States211940
08

Study locations

1 site
  • Columbia University Irving Medical Center
    New York, New York 10034, United States
09

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 6, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT02767427
Collaborators
Orthopaedic Scientific Research Foundation Inc
Responsible party
Kiehyun Riew (Professor of Orthopedic Surgery at the Columbia University Medical Center, Columbia University) — Principal investigator
First posted
May 10, 2016
Start date
Feb 2016
Primary completion
May 31, 2018
Completion
May 31, 2018
Results posted
Jul 16, 2019
Last update
Feb 6, 2023

Study contacts

Kiehyun D Riew, MD
principal investigator · Columbia University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion